Aromatic Amino Acid Decarboxylase Inhibitors [inhibitory dekarboxylasy aromatických aminokyselin]

topical
8
Terms

iDDC
inhibitory dekarboxylázy aromatických aminokyselin
inhibitory DOPA-dekarboxylasy
inhibitory DOPA-dekarboxylázy

 

Aromatic-L-Amino-Acid Decarboxylase Inhibitors
Dihydroxyphenylalanine Decarboxylase Inhibitors
DOPA Decarboxylase Inhibitors

Persistent link   https://www.medvik.cz/link/D065105
Definition

Compounds and drugs that block or inhibit the enzymatic action of AROMATIC AMINO ACID DECARBOXYLASES. Pharmaceutical agents in this category are used in conjunction with LEVODOPA in order to slow its metabolism.

DUI
D065105 MeSH Browser
CUI
M0587359
Previous indexing
Aromatic-L-Amino-Acid Decarboxylases/ Antagonists & Inhibitors (1998-2014)
History note
2015
Public note
2015

Allowable subheadings

AD
administration & dosage
AE
adverse effects
AN
analysis
BL
blood
CF
cerebrospinal fluid
CS
chemical synthesis
CH
chemistry
CL
classification
EC
economics
HI
history
IM
immunology
IP
isolation & purification
ME
metabolism
PK
pharmacokinetics
PD
pharmacology 1
PO
poisoning
RE
radiation effects
ST
standards
SD
supply & distribution
TU
therapeutic use 2
TO
toxicity
UR
urine

D Chemicals and Drugs
D27 Chemical Actions and Uses 374
D27.505 Pharmacologic Actions 410
D27.505.519 Molecular Mechanisms of Pharmacological Action 89
D27.505.519.389 Enzyme Inhibitors 883
D27.505.519.389.086 5-Lipoxygenase-Activating Protein Inhibitors 3
D27.505.519.389.089 Acetaldehyde Dehydrogenase Inhibitors 2
D27.505.519.389.092 Adenosine Deaminase Inhibitors 6
D27.505.519.389.108 Adenylyl Cyclase Inhibitors 14
D27.505.519.389.124 Aromatic Amino Acid Decarboxylase Inhibitors 8
D27.505.519.389.174 Calcineurin Inhibitors 124
D27.505.519.389.200 Carbonic Anhydrase Inhibitors 60
D27.505.519.389.237 Catechol O-Methyltransferase Inhibitors 31
D27.505.519.389.275 Cholinesterase Inhibitors 974
D27.505.519.389.310 Cyclooxygenase Inhibitors 454
D27.505.519.389.315 Gamma Secretase Inhibitors and Modulators
D27.505.519.389.320 Glycoside Hydrolase Inhibitors 48
D27.505.519.389.335 Cytochrome P-450 Enzyme Inhibitors 94
D27.505.519.389.350 Folic Acid Antagonists 67
D27.505.519.389.360 Histone Deacetylase Inhibitors 112
D27.505.519.389.370 Hydroxymethylglutaryl-CoA Reductase Inhibitors 1 856
D27.505.519.389.375 Integrase Inhibitors 6
D27.505.519.389.400 beta-Lactamase Inhibitors 75
D27.505.519.389.480 Lipoxygenase Inhibitors 51
D27.505.519.389.616 Monoamine Oxidase Inhibitors 155
D27.505.519.389.675 Nucleic Acid Synthesis Inhibitors 33
D27.505.519.389.705 Ornithine Decarboxylase Inhibitors 3
D27.505.519.389.735 Phosphodiesterase Inhibitors 405
D27.505.519.389.736 Phosphoinositide-3 Kinase Inhibitors 35
D27.505.519.389.737 Phospholipase A2 Inhibitors 9
D27.505.519.389.739 Poly(ADP-ribose) Polymerase Inhibitors 203
D27.505.519.389.740 Prolyl-Hydroxylase Inhibitors 3
D27.505.519.389.745 Protease Inhibitors 274
D27.505.519.389.755 Protein Kinase Inhibitors 1 393
D27.505.519.389.760 Protein Synthesis Inhibitors 37
D27.505.519.389.848 Proton Pump Inhibitors 499
D27.505.519.389.870 Steroid Synthesis Inhibitors 1
D27.505.519.389.892 Topoisomerase Inhibitors 7
D27.505.519.389.936 Uncoupling Agents 24
D27.505.954 Therapeutic Uses 62
D27.505.954.427 Central Nervous System Agents 241
D27.505.954.427.090 Anti-Dyskinesia Agents 3
D27.505.954.427.090.050 Antiparkinson Agents 213
D27.505.954.427.090.050.249 Aromatic Amino Acid Decarboxylase Inhibitors 8
D27.505.954.427.090.050.500 Catechol O-Methyltransferase Inhibitors 31

Back Add